108 related articles for article (PubMed ID: 7682488)
1. [The evaluation of the antiarrhythmic activity of L-carnitine and propafenone in ischemic cardiopathy].
Palazzuoli V; Mondillo S; Faglia S; D'Aprile N; Camporeale A; Gennari C
Clin Ter; 1993 Feb; 142(2):155-9. PubMed ID: 7682488
[TBL] [Abstract][Full Text] [Related]
2. [Therapy of arrhythmia induced by myocardial ischemia. Association of L-carnitine, propafenone and mexiletine].
Mondillo S; Faglia S; D'Aprile N; Mangiacotti L; Campolo MA; Agricola E; Palazzuoli V
Clin Ter; 1995 Dec; 146(12):769-74. PubMed ID: 8681496
[TBL] [Abstract][Full Text] [Related]
3. [Diprafenone--comparative study of anti-arrhythmia therapy with propafenone].
Geibel A; Zehender M; Hohnloser S; Landsrath C; Meinertz T; Just H
Z Kardiol; 1988 Jul; 77(7):464-9. PubMed ID: 2463720
[TBL] [Abstract][Full Text] [Related]
4. [Cibenzoline versus propafenone by the oral route for preventing recurrence of atrial arrhythmia: multicenter, randomized, double-blind study].
Lardoux H; Maison Blanche P; Marchand X; Canler A; Rouesnel P; Bleinc D; Péraudeau P; Scheck F
Ann Cardiol Angeiol (Paris); 1996 Oct; 45(8):469-79. PubMed ID: 8952741
[TBL] [Abstract][Full Text] [Related]
5. [Anti-arrhythmia treatment using L-carnitine in acute myocardial infarct].
Martina B; Zuber M; Weiss P; Burkart F; Ritz R
Schweiz Med Wochenschr; 1992 Sep; 122(37):1352-5. PubMed ID: 1384117
[TBL] [Abstract][Full Text] [Related]
6. [Propafenone and flecainide in the therapy of ventricular arrhythmias].
Paperini L; Davini A; Lattanzi F; Topi A; Reisenhofer B; Squarcini G; Paci A; Topi PL
Minerva Cardioangiol; 1995 Oct; 43(10):449-57. PubMed ID: 8819814
[TBL] [Abstract][Full Text] [Related]
7. [Evaluation of the anti-arrhythmic action of propafenone treatment and its influence on left ventricular function].
Saitta A; Bonaiuto M; Mileto A; Oriti S; Cinquegrani M; Giordano G; Fodale P; Saitta M; Squadrito F
Clin Ter; 1993 Apr; 142(4):351-60. PubMed ID: 8330479
[TBL] [Abstract][Full Text] [Related]
8. [Comparative study of the efficacy of propafenone and amiodarone in the treatment of chronic ventricular extrasystole].
Fauchier JP; Cosnay P; Rouesnel P; Moquet B; Huguet R; Wajman A
Arch Mal Coeur Vaiss; 1986 Sep; 79(10):1495-505. PubMed ID: 2432845
[TBL] [Abstract][Full Text] [Related]
9. [Propafenone in ventricular hyperkinetic arrhythmias. Dynamic ECG evaluation of the acute oral test and short-term treatment].
Garimoldi M; Sghirinzetti M; Pirastu A; Cappiello E; Sala R; Terranova P
G Ital Cardiol; 1986 Apr; 16(4):328-32. PubMed ID: 2427383
[TBL] [Abstract][Full Text] [Related]
10. [Antiarrhythmic efficacy of mexiletine, propafenone and flecainide in ventricular premature beats. A comparative study in patients after myocardial infarction (author's transl)].
Klempt HW; Nayebagha A; Fabry E
Z Kardiol; 1982 May; 71(5):340-9. PubMed ID: 6180562
[TBL] [Abstract][Full Text] [Related]
11. The evaluation of postdialysis L-carnitine administration and its effect on weekly requiring doses of rHuEPO in hemodialysis patients.
Kadiroglu AK; Yilmaz ME; Sit D; Kara IH; Isikoglu B
Ren Fail; 2005; 27(4):367-72. PubMed ID: 16060121
[TBL] [Abstract][Full Text] [Related]
12. [Sotalol, propafenone, and flecainide: compared multiparametric analysis of ventricular repolarization in subjects without organic cardiopathy].
Sarubbi B; Ducceschi V; Briglia N; Esposito R; Mayer MS; Scialdone A; Santangelo L; Iacono A
Cardiologia; 1996 Jul; 41(7):645-51. PubMed ID: 8983831
[TBL] [Abstract][Full Text] [Related]
13. [Clinical trial of propafenone (rytmonorm) in arrhythmia of patients with ischemic heart disease)].
Dobrotvorskaia TE; Koroleva ON; Gordina OV; Marakanova AV
Klin Med (Mosk); 1996; 74(3):51-3. PubMed ID: 8926706
[No Abstract] [Full Text] [Related]
14. [Double-blind randomized placebo-controlled study of the effects of slow release and immediate release forms of propafenone in patients ventricular extrasystole symptoms].
Mastropasqua F; Totaro P; Massari F; Pitzalis MV; Rizzon P
Cardiologia; 1998 Jun; 43(6):617-23. PubMed ID: 9675961
[TBL] [Abstract][Full Text] [Related]
15. [Significance of cardiac arrhythmias in the aged and their treatment with propafenone controlled by plasma level].
Lachnit KS; Rieder L
Z Gerontol; 1985; 18(6):343-52. PubMed ID: 2420079
[TBL] [Abstract][Full Text] [Related]
16. [The efficacy of propaphenol in extrasystole in patients with ischemic heart disease].
Dobrotvorskaia TE; Rybakova MK; Suprun EK; Arifullin ShS
Ter Arkh; 1992; 64(12):30-2. PubMed ID: 1284005
[No Abstract] [Full Text] [Related]
17. Antiarrhythmic effectiveness of propafenone compared to lorajmine in ventricular arrhythmias. Controlled clinical trial.
Sanna G; Meoli P; Bianchini C; Rovelli F
G Ital Cardiol; 1983; 13(3):145-51. PubMed ID: 6350090
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of the therapeutic efficacy of L-carnitine in congestive heart failure.
Ghidini O; Azzurro M; Vita G; Sartori G
Int J Clin Pharmacol Ther Toxicol; 1988 Apr; 26(4):217-20. PubMed ID: 3403101
[TBL] [Abstract][Full Text] [Related]
19. Preliminary study of the effects of metoprolol and propafenone on ventricular arrhythmia with positive ventricular late potential.
Gao E; Yang C; Li H; Duan Y; Zhou Y
Chin Med J (Engl); 1997 Sep; 110(9):723-5. PubMed ID: 9642335
[TBL] [Abstract][Full Text] [Related]
20. [The circadian profile of ventricular extrasystole].
Paisana JP; Gomes F; Cruz J; Bonhorst D; Lopes D; Schneider V; Bruges G; Gil C
Rev Port Cardiol; 1993 Jan; 12(1):7-8, 23-32. PubMed ID: 7686016
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
